Literature DB >> 2883197

Selective alterations in immunoregulatory lymphocyte subsets in early HIV (human T-lymphotropic virus type III/lymphadenopathy-associated virus) infection.

J V Giorgi, P G Nishanian, I Schmid, L E Hultin, H L Cheng, R Detels.   

Abstract

In order to characterize the effects of HIV (human T-lymphotropic virus type III/lymphadenopathy-associated virus) on the immune system, Leu8- and Leu8+ subsets of CD4 and CD8 cells were studied in seropositive homosexually active men without acquired immune deficiency syndrome (AIDS). Controls included both heterosexual men and HIV-seronegative homosexually active men. The decrease in CD4 levels, observed in HIV-seropositive men who were asymptomatic, as well as in those who had persistent generalized lymphadenopathy or constitutional symptoms of HIV infection, occurred proportionally in both the Leu8- and the Leu8+ CD4 subsets. This observation, that HIV infection does not selectively diminish either subset of CD4 cells, indicates that the selective loss of T cell-mediated functions which accompanies the development of AIDS is not related to preferential loss of the Leu8+ CD4 subset. Among CD8 cells, however, HIV infection resulted in a threefold elevation in the number of Leu8- CD8 cells, while the number of Leu8+ CD8 cells remained constant. The increase in Leu8- CD8 cells was present in recent seroconverters, persistently seropositive men, and patients with AIDS. We propose that the increase in Leu8- CD8 cells represents an HIV-specific cytotoxic T-cell response. These cells may operate by killing infected CD4 cells, thereby partially controlling viral infection while simultaneously contributing to the destruction of the immune system.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2883197     DOI: 10.1007/bf00916008

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  41 in total

1.  Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen.

Authors:  J H Phillips; L L Lanier
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

2.  The isolation and characterization of the human helper inducer T cell subset.

Authors:  C Morimoto; N L Letvin; A W Boyd; M Hagan; H M Brown; M M Kornacki; S F Schlossman
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

3.  Significance of quantitative enzyme-linked immunosorbent assay (ELISA) results in evaluation of three ELISAs and Western blot tests for detection of antibodies to human immunodeficiency virus in a high-risk population.

Authors:  P Nishanian; J M Taylor; E Korns; R Detels; A Saah; J L Fahey
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

4.  Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis.

Authors:  W P Carney; R H Rubin; R A Hoffman; W P Hansen; K Healey; M S Hirsch
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

5.  Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection.

Authors:  M G Sarngadharan; F diMarzo Veronese; S Lee; R C Gallo
Journal:  Cancer Res       Date:  1985-09       Impact factor: 12.701

6.  Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders.

Authors:  J L Fahey; H Prince; M Weaver; J Groopman; B Visscher; K Schwartz; R Detels
Journal:  Am J Med       Date:  1984-01       Impact factor: 4.965

7.  Immunoregulatory T cells in men with a new acquired immunodeficiency syndrome.

Authors:  E Benveniste; R Schroff; R H Stevens; M S Gottlieb
Journal:  J Clin Immunol       Date:  1983-10       Impact factor: 8.317

8.  Maturational and functional diversity of human B lymphocytes delineated with anti-Leu-8.

Authors:  G S Kansas; G S Wood; E G Engleman
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

9.  The acquired immunodeficiency syndrome in a cohort of homosexual men. A six-year follow-up study.

Authors:  H W Jaffe; W W Darrow; D F Echenberg; P M O'Malley; J P Getchell; V S Kalyanaraman; R H Byers; D P Drennan; E H Braff; J W Curran
Journal:  Ann Intern Med       Date:  1985-08       Impact factor: 25.391

Review 10.  Infection by the retrovirus associated with the acquired immunodeficiency syndrome. Clinical, biological, and molecular features.

Authors:  J A Levy; L S Kaminsky; W J Morrow; K Steimer; P Luciw; D Dina; J Hoxie; L Oshiro
Journal:  Ann Intern Med       Date:  1985-11       Impact factor: 25.391

View more
  16 in total

1.  Acquired immune deficiency syndrome (AIDS) and autoimmunity--mutually exclusive entities?

Authors:  A M Solinger; L E Adams; A E Friedman-Kien; E V Hess
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

2.  Preferential loss of Leu 8-, CD45R, HLA-DR+ CD8 cell subsets during in vitro culture of mononuclear cells from human immunodeficiency virus type I (HIV)-seropositive former blood donors.

Authors:  H E Prince; C D Czaplicki
Journal:  J Clin Immunol       Date:  1989-09       Impact factor: 8.317

3.  CDC staging based on absolute CD4 count and CD4 percentage in an HIV-1-infected Indian population: treatment implications.

Authors:  M Vajpayee; S Kaushik; V Sreenivas; N Wig; P Seth
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

4.  Inactivation of suppressor T-cell activity by nontoxic monophosphoryl lipid A.

Authors:  P J Baker; J R Hiernaux; M B Fauntleroy; B Prescott; J L Cantrell; J A Rudbach
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

5.  Inverse relationship of CD8+CD11+ suppressor T cells with human immunodeficiency virus (HIV)-specific cellular cytotoxicity and natural killer cell activity in HIV infection.

Authors:  S K Kundu; T C Merigan
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

6.  Determination of CD4 and CD8 lymphocyte subsets by a new alternative fluorescence immunoassay.

Authors:  T N Denny; B D Jensen; E I Gavin; A G Louzao; F A Vella; J M Oleske; W Wong
Journal:  Clin Diagn Lab Immunol       Date:  1995-05

7.  Loss of mucosal CD4 lymphocytes is an early feature of HIV infection.

Authors:  S G Lim; A Condez; C A Lee; M A Johnson; C Elia; L W Poulter
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

8.  Immunological functions and phenotypes of peripheral blood lymphocytes from human T-cell leukemia virus-I carriers.

Authors:  Y Tanaka; S Oda; K Nagata; N Mori; H Sakamoto; S Eto; U Yamashita
Journal:  J Clin Immunol       Date:  1989-11       Impact factor: 8.317

9.  Immunophenotypical alterations in a subset of patients with common variable immunodeficiency (CVID).

Authors:  E Baumert; G Wolff-Vorbeck; M Schlesier; H H Peter
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

10.  The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value.

Authors:  M Levacher; F Hulstaert; S Tallet; S Ullery; J J Pocidalo; B A Bach
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.